Hayato Watanabe

Company: Crafton Biotechnology

Job title: President & Chief Executive Officer

Seminars:

PureCap: Demonstrating an Ultra-Pure Next-Generation mRNA Cap Analog with Significantly Improved Potency Profile 11:30 am

The development of high quality mRNA vaccines and therapeutics hinges on the optimization of mRNA synthesis, particularly the capping process. PureCap is a nextgeneration mRNA cap analog designed to address key challenges in the field: purity, potency, and scalability Utilizing a photo-labile cap to deliver an ultra pure fully capped, fully functional mRNA product with…Read more

day: Conference Day One